Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI

Author

H. Dewangan

h-index 20 View on Semantic Scholar

We have 5 of 121 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Ultradeformable Vesicle-Loaded Smart Gels for Enhanced Ocular Bioavailability

Ocular drug delivery systems face significant challenges due to the physiological and anatomical barriers of the eyes. Nanotechnology has emerged as a promising approach to overcome these limitations and potentially improve ocular bioavailability and patient compliance. Lipid-based ultra-deformable vesicular system...

R. Thakur, Navneet Sharma, Kamal Shah et al. · 0 citations
Aug 2026

Innovations in Intranasal Nanocarrier Drug Delivery: Bridging the Gap Across the Blood-Brain Barrier

Overall, nanocarrier-assisted nose-to-brain drug delivery represents a transformative platform for the management of central nervous system disorders and has the potential to overcome the limitations of conventional drug delivery systems and improve therapeutic outcomes for a wide range of neurological diseases.

Alpana, H. Dewangan · 0 citations
Review Sep 2026

Targeted Therapeutics in Breast Cancer: Promise, Progress, and the Challenge of Triple-negative Subtype.

Advances in targeted and immune-based therapies are transforming breast cancer care and Leveraging molecular insights, particularly for TNBC, is crucial to delivering personalised, clinically meaningful treatments and improving outcomes across all subtypes.

S. Sengupta, Ruhi Arisha, Kamal Shah et al. · 0 citations
Aug 2026

Design, Development, and Characterization of Carmustine-Loaded Nanostructured Lipid Carriers for Enhanced Brain Accumulation and Antitumor Efficacy in Glioblastoma

In-vivo studies showed a reduction in tumor volume, increased accumulation of the drug in the brain, and enhanced antioxidant enzyme levels, with favorable pharmacokinetics, indicating that the nanoparticles are a promising system for the management of glioblastoma.

H. Dewangan, N. Garg, Bharat Bhushan et al. · 0 citations
Review Aug 2026

Molecular pathways and emerging therapeutic strategies in advanced thyroid cancer: from targeted therapy to precision oncology.

Collectively, the advances are an indication of a transition to the personalized, mechanism-driven treatment strategies that would prolong the survivability of patients with advanced thyroid cancer, conquer resistance, and reduce systemic toxicity.

Tanmoy Sarkar, Ruhi Arisha, S. Sengupta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.